[{"data":1,"prerenderedAt":48},["ShallowReactive",2],{"q-nurse-110-1-basic-medicine-049":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":23},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"freq":11},"nurse-110-1-基礎醫學-049","nurse-110-1-basic-medicine-049",110,1,49,"國產藥物與外國原廠的藥物，口服後之時間-血中濃度曲線下之面積相同時，表示此兩種藥物具有何種相同性質？",{"A":15,"B":16,"C":17,"D":18},"生體可用率（bioavailability）","首渡效應（first-pass effect）","藥物代謝速率（metabolic rate）","生體相等性（bioequivalence）","D",null,[],"本題考點是生體相等性的定義。依藥物動力學,口服後「時間-血中濃度曲線下面積(AUC)」代表藥物進入全身循環的總量;當國產藥與原廠藥的 AUC 相同,代表兩者在體內可獲得的藥量與速率一致,即具生體相等性,故選 D。考點在於區分相近名詞:A 生體可用率是單一藥物本身被吸收進入循環的比率,是量測指標而非兩藥「相等」的結論;B 首渡效應指藥物經肝臟先被代謝而減少,屬機轉;C 藥物代謝速率是清除的快慢,三者皆非描述兩產品等效的專有名詞。",[24,28,32,36,40,44],{"webId":25,"stem":26,"number":11,"year":27,"session":11},"nurse-106-1-basic-medicine-001","下列有關表皮的敘述，何者正確？",106,{"webId":29,"stem":30,"number":31,"year":27,"session":11},"nurse-106-1-basic-medicine-002","下列何者在組織學特徵上可區分為絲球帶（zona glomerulosa）、束狀帶（zona fasciculata）、網狀帶（zona reticularis）？",2,{"webId":33,"stem":34,"number":35,"year":27,"session":11},"nurse-106-1-basic-medicine-003","顴弓（zygomatic arch）是由顴骨與下列何者共同組成？",3,{"webId":37,"stem":38,"number":39,"year":27,"session":11},"nurse-106-1-basic-medicine-004","下列何者參與形成踝關節？",4,{"webId":41,"stem":42,"number":43,"year":27,"session":11},"nurse-106-1-basic-medicine-005","下列何者是維持背部直立最重要的肌肉？",5,{"webId":45,"stem":46,"number":47,"year":27,"session":11},"nurse-106-1-basic-medicine-006","行走於前臂的內側，並與上臂深層的靜脈會合成腋靜脈的是那一條血管？",6,1783840761099]